Français
ItalianoBond Gilead Sciences 1.95% ( US375558BH51 ) in USD
| Issuer | Gilead Sciences | ||||||
| Market price | 99.51 % ⇌ | ||||||
| Country |  United States
|
||||||
| ISIN code |
 US375558BH51 ( in USD )
|
||||||
| Interest rate | 1.95% per year ( payment 2 times a year) | ||||||
| Maturity | 01/03/2022 - Bond has expired | ||||||
|
|||||||
| Minimal amount | 2 000 USD | ||||||
| Total amount | 500 000 000 USD | ||||||
| Cusip | 375558BH5 | ||||||
| Standard & Poor's ( S&P ) rating | BBB+ ( Lower medium grade - Investment-grade ) | ||||||
| Moody's rating | NR | ||||||
| Detailed description |
Gilead Sciences is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapeutics in areas of unmet medical need, primarily in HIV/AIDS, viral hepatitis, and oncology. The Bond issued by Gilead Sciences ( United States ) , in USD, with the ISIN code US375558BH51, pays a coupon of 1.95% per year. The coupons are paid 2 times per year and the Bond maturity is 01/03/2022 The Bond issued by Gilead Sciences ( United States ) , in USD, with the ISIN code US375558BH51, was rated NR by Moody's credit rating agency. The Bond issued by Gilead Sciences ( United States ) , in USD, with the ISIN code US375558BH51, was rated BBB+ ( Lower medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||
| |||||||
